2,4,6-Trihydroxybenzaldehyde | CAS:487-70-7

We serve 2,4,6-Trihydroxybenzaldehyde CAS:487-70-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4,6-Trihydroxybenzaldehyde

CAS No: 487-70-7
Product Name: 2,4,6-Trihydroxybenzaldehyde
Other Name:
2,4,6-Trihydroxybenzaldehyde
Phloroglucinolcarboxaldehyde
 
Density: 1.6±0.1 g/cm3
Boiling Point: 319.1±22.0 °C at 760 mmHg
Melting Point: 195 °C (dec.)(lit.)
Molecular Formula: C7H6O4
Molecular Weight: 154.120
Flash Point: 161.0±18.8 °C
Exact Mass: 154.026611
PSA: 77.76000
LogP: 1.37
Vapour Pressure: 0.0±0.7 mmHg at 25°C
Index of Refraction: 1.734
 
Specification
Appearance: Yellow powder
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2,4,6-Trihydroxybenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phloroglucinolcarboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4,6-Trihydroxybenzaldehyde Use and application,Phloroglucinolcarboxaldehyde technical grade,usp/ep/jp grade.


Related News: Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.9-bromo-1-nonanol acetate manufacturer Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease.2-BROMO-5-(TRIFLUOROMETHYL)BENZALDEHYDE supplier “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.6-fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene vendor The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.